Gabrielle is an NHMRC Australian Public Health Early Career Fellowship recipient and has worked at the National Drug and Alcohol Research Centre (NDARC), Faculty of Medicine, UNSW, since 2006. Gabrielle's research interests include pharmaceutical opioids, opioid dependence and suicidal behaviours amongst people living with chronic non-cancer pain. She currently coordinates a large prospective study examining the benefits and outcomes of prescription opioids for chronic pain, the Pain and Opioids IN Treatment (POINT) study.

Prof Nicholas Lintzeris (MBBS, PhD, FAChAM) has worked in addiction medicine for over 25 years, in clinical, research, policy and workforce development domains. A career long focus has been in the intersection between the medical and illicit use of a range of substances, including heroin, amphetamines, benzodiazepines and cannabinoids.

Dr. Yifrah Kaminer main interest has been focusing on clinical research of the assessment, treatment and continuity of care of substance use disorders in youth. He has special interest in co-occurring depressive disorders. He has received US research funding from NIAAA, NIDA, and CSAT and his research team developed treatment and continued care manuals including the MET and CBT manuals for the Multisite Cannabis Youth Treatment (CYT) study. Dr. Kaminer has developed several rating scales including: the Teen Addiction Severity Index (T-ASI), the Teen Treatment Services Review (T-TSR) and the Adolescent Substance Abuse and Goal Commitment questionnaire (ASAGC-Q). He authored 150 scientific publications, served as a guest editor of 4 special issues on adolescent substance abuse and published 5 books including: a) Brief Telephone Continuing Care Therapy for Adolescents, Hazelden, (2010); b) Clinical Manual of Adolescent Substance Abuse Treatment, American Psychiatric Publishing (2011); c) Youth substance abuse and co-occurring disorders, American Psychiatric Publishing (2016). Dr. Kaminer is the coordinator of the Youth Treatment Section of the advisory board of the Research Society on Marijuana (RSMj) and is on the clinical advisory board of Smart Approach to marijuana (SAM).

Simon is the Director of the National Drug Research Institute in Perth and has a long history of research work on cannabis policy